Published in J Interferon Cytokine Res on June 01, 1998
Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx (2005) 0.98
Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis. J Neuroinflammation (2006) 0.86
Oral lesions in sheep and cattle in Dumfries and Galloway. Vet Rec (2001) 7.78
A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA (1992) 6.88
Determinants of HIV-1 shedding in the genital tract of women. Lancet (2001) 5.10
Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A (1976) 4.89
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J Clin Invest (1993) 4.53
The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact (1974) 3.91
Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A (1991) 3.43
Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A (1978) 3.14
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2007) 3.12
Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lancet (1998) 2.98
Impact of filmless radiology on frequency of clinician consultations with radiologists. AJR Am J Roentgenol (1999) 2.89
Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology (2011) 2.47
Decline in neonatal mortality, 1968 to 1977: better babies or better care? Pediatrics (1983) 2.46
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun (1997) 2.44
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg (2000) 2.39
Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health (1981) 2.39
Reduction of transmission of shigellosis by control of houseflies (Musca domestica) Lancet (1991) 2.30
Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology (2010) 2.29
The cost of delaying treatment in multiple sclerosis: what is lost is not regained. Neurology (2001) 2.27
Mitral prosthetic replacement in small left atria. Ann Thorac Surg (1990) 2.25
The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance. Chem Biol Interact (1974) 2.07
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis (1994) 2.03
Some approaches to family planning counseling in local health departments: a survey of Public Health nurses and physicians. Am J Public Health Nations Health (1966) 2.00
Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases. Oncology (1973) 1.91
Ascorbic acid and cancer: a review. Cancer Res (1979) 1.88
The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol Interact (1975) 1.82
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood (2001) 1.80
Prediction in family planning. Factors associated with involvement of low-income women in a public family planning program. Am J Public Health Nations Health (1970) 1.77
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine (1995) 1.74
Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect Immun (1992) 1.72
Transmission failure rate for computed tomography examinations in a filmless imaging department. J Digit Imaging (2000) 1.69
Evaluation of soft-tissue foreign bodies: comparing conventional plain film radiography, computed radiography printed on film, and computed radiography displayed on a computer workstation. AJR Am J Roentgenol (1996) 1.69
Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci U S A (1997) 1.69
Seroprevalence of Helicobacter pylori in Seventh-Day Adventists and other groups in Maryland. Lack of association with diet. Arch Intern Med (1990) 1.68
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine (2000) 1.67
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun (1999) 1.66
Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes (2009) 1.65
Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei. Infect Immun (1990) 1.64
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun (2000) 1.63
Biological function of ascorbic acid and the pathogenesis of scurvy: a working hypothesis. Med Hypotheses (1976) 1.62
Measuring the impact of programs for mothers and infants on prenatal care and low birth weight: the value of refined analyses. Med Care (1983) 1.62
Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis (1993) 1.59
Infant mortality: a practical approach to the analysis of the leading causes of death and risk factors. Pediatrics (1990) 1.58
An analysis of the quantitative relationship between oral temperature and severity of illness in experimental shigellosis. J Infect Dis (1992) 1.55
Work-related psychosocial stress and risk of preterm, low birthweight delivery. Am J Public Health (1990) 1.50
Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun (2001) 1.50
Don't forget dengue! Clinical features of dengue fever in returning travellers. J R Coll Physicians Lond (1998) 1.49
Pulmonary endothelial permeability and circulating neutrophil-endothelial markers in patients undergoing esophagogastrectomy. Crit Care Med (2000) 1.44
Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles. Eur J Clin Invest (2009) 1.44
Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol (2001) 1.42
[Complications of diagnostic laparoscopy]. Dtsch Med Wochenschr (2005) 1.42
Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels. Infect Immun (1993) 1.40
A longitudinal assessment of the characteristics of new admissions to a community family planning program. Am J Public Health Nations Health (1968) 1.38
Hemolytic disease of the newborn. Review of deaths in California. Calif Med (1966) 1.38
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2. Vaccine (1995) 1.38
Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J (1996) 1.38
Continuation of contraception by low income women: a one year follow-up. Am J Public Health (1971) 1.36
Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial. Infect Immun (1992) 1.35
Prognosis of ocular myasthenia. Ann Neurol (1983) 1.35
Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J Infect Dis (1999) 1.35
Multilayered distribution of peptidoglycan in the periplasmic space of Escherichia coli. J Gen Microbiol (1989) 1.32
Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect Immun (1996) 1.32
Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group. J Clin Microbiol (2000) 1.31
The evaluation of Regionalized Perinatal Health Care Programs. Am J Obstet Gynecol (1976) 1.30
Goldfish, Carassius auratus, a novel animal model for the study of Mycobacterium marinum pathogenesis. Infect Immun (1998) 1.28
Reliability and acceptability of psychiatric diagnosis via telecommunication and audiovisual technology. Psychiatr Serv (1998) 1.27
Home visitors and child health: analysis of selected programs. Pediatrics (1990) 1.26
Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun (2001) 1.23
Family planning: its health rationale. Am J Obstet Gynecol (1974) 1.23
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia (1984) 1.23
Understanding financing options for PACS implementation. Picture archiving and communication systems. J Digit Imaging (2000) 1.22
Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera. Infect Immun (1996) 1.21
Teledermatology and in-person examinations: a comparison of patient and physician perceptions and diagnostic agreement. Arch Dermatol (1998) 1.21
Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. J Clin Invest (1992) 1.21
Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol (1992) 1.20
Characterization of translational-control ribonucleic acid isolated from embryonic chick muscle. Biochemistry (1983) 1.19
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J Infect Dis (1994) 1.19
Cholera-like diarrhea in Canada. Report of a case associated with enterotoxigenic Escherichia coli and a toxin-producing Aeromonas hydrophila. Arch Intern Med (1977) 1.19
Polarity and rate of transport of cyclic adenosine 3,5'-monophosphate in the coleoptile. Plant Physiol (1973) 1.16
Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect Immun (1997) 1.15
A voluntary serosurvey and behavioral risk assessment for human immunodeficiency virus infection among college students. Sex Transm Dis (1992) 1.15
Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin Immunol (2000) 1.14
A controlled evaluation of rural regional perinatal care: impact on mortality and morbidity. Am J Public Health (1985) 1.14
Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years. Br J Haematol (2001) 1.13
Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor. Neurology (1982) 1.13
Capsule endoscopy versus push enteroscopy in patients with occult gastrointestinal bleeding. Z Gastroenterol (2003) 1.12
Hospital and home support during infancy: impact on maternal attachment, child abuse and neglect, and health care utilization. Pediatrics (1980) 1.10
Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region. Int J Cancer (1993) 1.07
Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival. Oncogene (2008) 1.07
A familial neurological disease complex in a Bedfordshire community. J R Coll Gen Pract (1974) 1.06
Variations in UDP-N-acetylglucosamine and UDP-N-acetylmuramyl-pentapeptide pools in Escherichia coli after inhibition of protein synthesis. J Bacteriol (1989) 1.06
Work-related physical exertion and risk of preterm, low birthweight delivery. Paediatr Perinat Epidemiol (1990) 1.06
Boric acid toxicity. Pediatr Clin North Am (1986) 1.06
Acute diarrhea in Baltimore children attending an outpatient clinic. Pediatr Infect Dis J (1988) 1.05
Pain on injection of prilocaine plain vs. lidocaine with epinephrine. A prospective double-blind study. J Am Dent Assoc (2001) 1.04
Characteristics of maternal employment during pregnancy: effects on low birthweight. Am J Public Health (1991) 1.04
Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen. Infect Immun (1999) 1.04
Possible role for calmodulin in insulin release. Studies with trifluoperazine in rat pancreatic islets. J Clin Invest (1980) 1.04
Effect of priming with carrier on response to conjugate vaccine. Lancet (1989) 1.03